Evidence map›Paper›PMID 31021316›Full record

ArticleeLife2019

Reporter-ChIP-nexus reveals strong contribution of the

Wanqing Shao, Sergio G-M Alcantara, Julia Zeitlinger

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Core promoterome of barley embryo.Computational and structural biotechnology journal · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The Core Promoter Is a Regulatory Hub for Developmental Gene Expression.Frontiers in cell and developmental biology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wanqing ShaoStowers Institute for Medical Research, Kansas City, United States.ORCID 0000-0003-4234-2095
Sergio G-M AlcantaraStowers Institute for Medical Research, Kansas City, United States.ORCID 0000-0003-3695-4677
Julia ZeitlingerStowers Institute for Medical Research, Kansas City, United States.ORCID 0000-0002-5172-3335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA polymerase II (Pol II) pausing is a general regulatory step in transcription, yet the stability of paused Pol II varies widely between genes. Although paused Pol II stability correlates with core promoter elements, the contribution of individual sequences remains unclear, in part because no rapid assay is available for measuring the changes in Pol II pausing as a result of altered promoter sequences. Here, we overcome this hurdle by showing that ChIP-nexus captures the endogenous Pol II pausing on transfected plasmids. Using this reporter-ChIP-nexus assay in

Indexed as

Enzyme StabilityTranscription, GeneticAnimalsCell LineDrosophilaGenes, ReporterMolecular BiologyPlasmidsRNA, MessengerRNA Polymerase IITransfectionRNA, MessengerRNA Polymerase IIchromosomescore promoter elementD. melanogastergene expressionKc167 cellsreporter-ChIP-nexusRNA polymerase II pausingTFIID

Identifiers

PMID31021316
PMCPMC6483594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.